Your browser doesn't support javascript.
loading
Publication rates of podium presentations at the Society of Gynecologic Oncology (SGO) annual meetings.
Chua, Katherine Jane; Moughrabi, Samira; Glassman, Danielle; Habib, Samer; Singer, Eric A; Girda, Eugenia.
Afiliação
  • Chua KJ; Gynecology Oncology, University of California Davis Health System, Sacramento, California, USA katherine.chua168@gmail.com.
  • Moughrabi S; California State University Dominguez Hills School of Nursing, Carson, California, USA.
  • Glassman D; Obstetrics and Gynecology, Rutgers Robert Wood Johnson Medical School New Brunswick, New Brunswick, New Jersey, USA.
  • Habib S; The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Singer EA; The Ohio State University Comprehensive Cancer Center Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, Ohio, USA.
  • Girda E; Gynecology Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Int J Gynecol Cancer ; 33(8): 1203-1207, 2023 08 07.
Article em En | MEDLINE | ID: mdl-37220952
ABSTRACT

OBJECTIVES:

Our study aimed to determine the publication rates of podium presentations from the 2017 and 2018 Society of Gynecologic Oncology (SGO) Annual Meetings; and to examine rates and predictors of oral presentations that resulted in publication.

METHODS:

We reviewed podium presentations given at the 2017 and 2018 SGO Annual Meetings. Abstracts were evaluated for publication from January 1, 2017 to March 30, 2020 and January 1, 2018 to June 30, 2021, respectively, to allow for a 3 year period of publication.

RESULTS:

In 2017 and 2018, 43 of 75 (57.3%) and 47 of 83 (56.6%) podium presentations were published within 3 years, respectively. No significant difference was found between the mean time to publication within 3 years (13.0 months vs 14.1 months for 2017 and 2018, respectively; p=0.96). Similarly, the mean difference of journal impact factors between both years did not reach significance (6.57 and 10.7 for 2017 and 2018, respectively; p=0.09). The median impact factor (IF) was 4.54 (range 40.3) and 4.62 (range 70.7) in 2017 and 2018, respectively. Of the presentations published, 53.4% (2017) and 38.3% (2018) appeared in the journal Gynecologic Oncology. Significant positive correlations for the likelihood of publication were determined among the following funding status (r=0.93) including funding involving National Institutes for Health (r=0.91) or pharmaceutical (r=0.95), clinical trial study design (r=0.94), and pre-clinical research (r=0.95) (all p<0.005).

CONCLUSIONS:

At the 2017 and 2018 SGO Annual Meetings 57% of podium presentations were published in a peer-reviewed journal within 3 years. Publication in peer-reviewed journals is crucial for timely distribution of clinical information to the medical community.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Sociedades Médicas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Sociedades Médicas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article